Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Promega; Sigma-Aldrich; HistoRx; Med fusion

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Promega this week said that its Maxwell 16 IVD System has been CE Marked in Europe. The CE Mark applies to the Maxwell 16 Blood DNA Purification System and the Maxwell 16 Viral Total Nucleic Acid Purification System. Promega said that the system supports clinical labs performing diagnostic tests in molecular pathology, transplant HLA, and infectious disease.


Sigma-Aldrich this week said that it has signed an agreement to acquire Ace Animals, a provider of research rodents. The firm said that the acquisition will enhance its portfolio of next-generation knockout and knockin rat models that have specific gene deletions, insertions, repressions, and modifications created using its CompoZr zinc finger nuclease technology. Terms of the acquisition were not disclosed.


HistoRx has received a loan of $1.5 million from Connecticut Innovations, which the Rocky Hill, CT.-based firm will use to build out its lab space and purchase equipment. HistoRx's Aqua technology quantifies specific protein expression within different parts of the cell within cancerous tissue samples. The firm is providing the technology to biotech and pharmaceutical firms as an aid in determining which drugs may be best suited to a particular patient's cancer. Connecticut Innovations is the state's quasi-public authority for technology investing and innovation development.


Med fusion, a new clinical lab and clinical trials services firm, will begin operations this spring, the firm announced Thursday. Med fusion is a collaboration between the Baylor Health Care System, Texas Oncology, Pathologists Biomedical Laboratories, and US Oncology. Among its services will be pathology testing and molecular diagnostics, the Dallas-based firm said. Med fusion intends to hire 320 employees next year and have more than 900 employees by 2014.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.